forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Receptor Agonist Market Report, 2033 GLP-1 Market Size, Share |

Semaglutide, the active ingredient in Novo Nordisks Ozempic and Wegovy, has been in short supply since March 2022 amid the drugs surging popularity

The SELECT trial has set Wegovy apart by showing that significant weight loss combined with cardiovascular protection is possible with a single medicine

Coverage has expanded steadily since Wegovy's 2021 approval but remains uneven

Without prescription drug insurance coverage, the list price for Zepbound is over $1,000 for a 4-week supply of medication

Unlike single-action drugs, this compound activates three distinct receptor pathways simultaneously: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors

The pen should always be stored with the cap on to protect it from light and contamination, and the needle should be removed after each use